Parnassus Investments, LLC Bristol Myers Squibb CO Transaction History

Parnassus Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $85.7 Million - $102 Million	-1,900,000 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $78 Million - $101 Million	-1,600,000 Reduced 45.71%	1,900,000 $98.8 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $5.52 Million - $6.23 Million	-100,000 Reduced 2.78%	3,500,000 $217 Million
Q2 2018 Aug 06, 2018	BUY	$50.53 - $62.98 $5.05 Million - $6.3 Million	100,000 Added 2.86%	3,600,000 $199 Million
Q1 2018 Apr 30, 2018	BUY	$59.92 - $68.98 $41.9 Million - $48.3 Million	700,000 Added 25.0%	3,500,000 $221 Million
Q4 2017 Feb 05, 2018	BUY	$59.94 - $65.35 $5.99 Million - $6.53 Million	100,000 Added 3.7%	2,800,000 $172 Million
Q3 2017 Nov 01, 2017	BUY	$55.23 - $63.74 $149 Million - $172 Million	2,700,000	2,700,000 $172 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Parnassus Investments, LLC with notifications on news.